You haven't searched anything yet.
Description
Transforming what patients can expect from cancer therapy takes passion and a strong dedicated team. When you join ADC Therapeutics, you will join a group of talented people who share this mission.
Why ADC Therapeutics
ADC Therapeutics (NYSE): is a commercial, global leader and pioneer in the field of antibody-drug conjugates (ADCs) with a constantly expanding technology toolbox. We are experts in the lifecycle of ADCs – starting with creation all the way through to commercialization. We have a robust pipeline of ADCS in clinical trials for both hematologic and solid tumor cancers. Our CD-19-directed ADC for relapsed/refractory non-Hodgkin lymphoma, ZYNLONTA® (loncastuxamab tesirine lpyl) has been approved in the United States and has also received European Commission approval. ZYNLONTA is also being evaluated in combination with other anti-cancer therapeutics to determine if it has potential to treat an even broader range of patients. We are a team of over 300 patient-focused, purpose-driven employees who carry out our mission in a flexible work environment. If you’re interested in making a difference in the lives of patients worldwide with a team of like-minded colleagues, come join us on our journey!
To learn more about ADC Therapeutics, please visit us at https://adctherapeutics.com/ and follow us on LinkedIn.
Position Overview
The Sr. Director Clinical Development Physician is responsible for working primarily across late stage clinical programs as well as potentially some early stage programs across the organization. For late phase clinical development, the role will assume responsibility for one or more clinical studies that focus on specific indications/label extensions or a whole development program until filing, and further for life cycle management. They may also assist on early stage programs, and work closely with the VP of Early Phase Development and the R&D line function on preclinical programs to ensure appropriate planning for the filing of INDs to become the clinical program lead on first in human (FIH) studies for these molecules.
An important part of the responsibility is to work cross-functionally with multiple other disciplines within the company on strategic development plans for initial registration and beyond in the US, but potentially across all geographic areas. As clinical program lead for late phase programs, they will be a pivotal member of select review and governance committees across the organization
The position will report to the VP of Late Stage Development and ideally will be located on the East Coast with the ability to travel to the New Providence, NJ office on a regular basis and travel as needed for business meetings and other on-site visits.
What You’ll Do:
Requirements
Who You Are:
The successful candidate will be an innovative, sophisticated, and highly creative individual who thrives in a “get it done” type of environment with a strong track record of hands-on experience in oncology clinical development. They will have the following mix of personal and professional characteristics:
ADC Therapeutics is proud to be an Affirmative Action/EEO Employer. EOE Minorities/Females/Protected Veterans/Disabled. We are committed to building diverse teams and fostering an inclusive, professional, and respectful work environment where employees are empowered for success.
Attention: Search firms/Third-party recruitment agencies
The People team manages the recruiting for all positions at ADC Therapeutics. We will only accept résumés from a search agency/recruiter if we have a signed agreement in place and we have formally requested your help on a specific role. Forwarding unsolicited resumes on behalf of potential candidates and/or vendor engagement requests to ADC Therapeutics hiring managers is strictly prohibited. Unsolicited résumés sent to ADCT will be considered property of ADCT. We will not be responsible for any fees associated should we hire from unsolicited résumés. Please send all emails and requests to recruiting@adctherapeutics.com.
Full Time
$239k-319k (estimate)
03/05/2024
05/02/2024